SOD2 and osteosarcoma: In osteosarcoma, the lncRNA GClnc1 facilitates tumor progression by stabilizing NONO and preventing FBXW7-mediated ubiquitination (307), whereas targeting miR-27a−3p can restore FBXW7 expression to sensitize Taxol−resistant cells (308).